{"id":"https://openalex.org/W7098426288","doi":null,"title":"II. The Incretin Axis","display_name":"II. The Incretin Axis","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7098426288"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.733.9701","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.733.9701","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.glucagon.com/pdfs/er.2011-1052.Ussher.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7098426288"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John R. Ussher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John R. Ussher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057472647","display_name":"Daniel J. Drucker","orcid":"https://orcid.org/0000-0001-6688-8127","observed_orcids":["https://orcid.org/0000-0001-6688-8127"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel J. Drucker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A. Glucagon-like Peptide","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Glucagon-like Peptide","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9390000104904175},{"id":"https://openalex.org/keywords/dipeptidyl-peptidase-4","display_name":"dipeptidyl peptidase IV","score":0.9559999704360962},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cardiovascular-effects","display_name":"cardiovascular effects","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.9559999704360962},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6710000038146973},{"id":"https://openalex.org/keywords/ischemic-heart-disease","display_name":"ischemic heart disease","score":0.8600000143051147},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.9021999835968018},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8356000185012817},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6305999755859375},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5891000032424927},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5782999992370605},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5644000172615051},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.482699990272522},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4221999943256378},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.38449999690055847},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.3709999918937683},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3619999885559082},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.329800009727478},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30979999899864197},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.3086000084877014},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2985000014305115},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2973000109195709},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.2962999939918518},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2946999967098236},{"id":"https://openalex.org/C555175668","wikidata":"https://www.wikidata.org/wiki/Q539690","display_name":"Angiology","level":2,"score":0.2928999960422516},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.25119999051094055}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.733.9701","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.733.9701","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.glucagon.com/pdfs/er.2011-1052.Ussher.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2029071587","https://openalex.org/W1968925787","https://openalex.org/W2150012656","https://openalex.org/W2019448874","https://openalex.org/W4205521731","https://openalex.org/W1981523468","https://openalex.org/W2055156006","https://openalex.org/W2013299013","https://openalex.org/W2160286139","https://openalex.org/W2134250131"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"(GLP-1)":[2],"is":[3,171],"an":[4],"incretin":[5,26,45,52],"hormone":[6],"that":[7,50],"enhances":[8],"glucose-stimulated":[9],"insulin":[10],"secretion":[11,159],"and":[12,15,23,58,80,85,98,105,118,163,185],"exerts":[13],"direct":[14,84],"indirect":[16,86],"actions":[17,111,130,177],"on":[18,88,131,174],"the":[19,35,64,74,93,158,175,195],"cardiovascular":[20,75,116,176,187,196,209],"system.":[21],"GLP-1":[22,54],"its":[24],"related":[25],"hormone,":[27],"glucose-dependent":[28],"insulinotropic":[29],"polypeptide,":[30],"are":[31,61],"rapidly":[32],"inactivated":[33],"by":[34],"enzyme":[36],"dipeptidyl":[37],"peptidase":[38],"4":[39],"(DPP-4),":[40],"a":[41,149,190],"key":[42],"determinant":[43],"of":[44,66,77,95,115,152,160,178,194,201,207],"bioactivity.":[46],"Two":[47],"classes":[48],"ofmedications":[49],"enhance":[51],"action,":[53],"receptor":[55],"(GLP-1R)":[56],"agonists":[57,79],"DPP-4":[59,81,106],"inhibitors,":[60,82],"used":[62],"for":[63],"treatment":[65],"type":[67,217],"2":[68,218],"diabetes":[69,184,219],"mellitus.":[70,220],"We":[71],"review":[72],"herein":[73],"biology":[76],"GLP-1R":[78,103],"including":[83],"effects":[87],"cardiomyocytes,":[89],"blood":[90,96,155],"vessels,":[91],"adipocytes,":[92],"control":[94,142,147],"pressure,":[97,156],"postprandial":[99],"lipoprotein":[100],"secretion.":[101],"Both":[102],"activation":[104],"inhibition":[107],"exert":[108],"multiple":[109],"cardiopro-tective":[110],"in":[112,121,134,166,181,214],"preclinical":[113,167],"models":[114],"dysfunction,":[117],"short-term":[119],"studies":[120,211],"human":[122],"subjects":[123,135],"appear":[124],"to":[125,198],"demonstrate":[126],"modest":[127],"yet":[128],"beneficial":[129],"cardiac":[132],"function":[133],"with":[136,148,183,216],"ischemic":[137],"heart":[138],"disease.":[139,188],"Incretin-based":[140],"agents":[141,180],"body":[143],"weight,":[144],"improve":[145],"glycemic":[146],"low":[150],"risk":[151,197],"hypogly-cemia,":[153],"decrease":[154],"inhibit":[157],"intestinal":[161],"chylomicrons,":[162],"reduce":[164],"inflammation":[165],"studies.":[168],"Nevertheless,":[169],"there":[170],"limited":[172],"information":[173],"these":[179],"patients":[182,215],"established":[186],"Hence,":[189],"more":[191],"complete":[192],"under-standing":[193],"benefit":[199],"ratio":[200],"incretin-based":[202],"therapies":[203],"will":[204],"require":[205],"completion":[206],"long-term":[208],"outcome":[210],"currently":[212],"underway":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7098426288","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-27T00:00:00"}
